Drugs / clinical grade umbilical cord mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02277145 | Oct 2014 → Dec 2018 | postinflammatory pulmonary fibrosis | Jianwu Dai | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | clinical grade umbilical cord mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02277145 ↗ |
| Known as | MSCs | “clinical grade umbilical cord mesenchymal stem cells (MSCs)” NCT02277145 ↗ |
| Modality | Cell therapy | “clinical grade umbilical cord mesenchymal stem cells (MSCs)” NCT02277145 ↗ |
| Route | Other | “injected via fiberoptic bronchoscopy” NCT02277145 ↗ |